Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan André

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Circulation|February 18, 2004
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trialChristoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, et al.
Dalton Transactions (Cambridge, England : 2003)|December 1, 2010
Tripodal imidazole frameworks: Reversible vapour sorption both with and without significant structural changesCharlotte E Willans, Sara French, Kirsty M Anderson, et al.
Thrombosis Research|January 31, 2006
Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trialCaroline Schmidt-Lucke, W Dieter Paar, Christoph Stellbrink, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Circulation|February 18, 2004
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trialChristoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, et al.
Dalton Transactions (Cambridge, England : 2003)|December 1, 2010
Tripodal imidazole frameworks: Reversible vapour sorption both with and without significant structural changesCharlotte E Willans, Sara French, Kirsty M Anderson, et al.
Thrombosis Research|January 31, 2006
Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trialCaroline Schmidt-Lucke, W Dieter Paar, Christoph Stellbrink, et al.
Pageof 2